THBS1 and Hyperglycemia: Similar to STZ-treated ApoE−/−, TSP-1−/−/ApoE−/− dKO mice developed significant hyperglycemia upon STZ treatment achieving non-fasted blood glucose levels ≥ 250 mg/dl.